Schwab Susan R, Pereira João P, Matloubian Mehrdad, Xu Ying, Huang Yong, Cyster Jason G
Howard Hughes Medical Institute and Department of Microbiology and Immunology, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143-0414, USA.
Science. 2005 Sep 9;309(5741):1735-9. doi: 10.1126/science.1113640.
Lymphocyte egress from the thymus and from peripheral lymphoid organs depends on sphingosine 1-phosphate (S1P) receptor-1 and is thought to occur in response to circulatory S1P. However, the existence of an S1P gradient between lymphoid organs and blood or lymph has not been established. To further define egress requirements, we addressed why treatment with the food colorant 2-acetyl-4-tetrahydroxybutylimidazole (THI) induces lymphopenia. We found that S1P abundance in lymphoid tissues of mice is normally low but increases more than 100-fold after THI treatment and that this treatment inhibits the S1P-degrading enzyme S1P lyase. We conclude that lymphocyte egress is mediated by S1P gradients that are established by S1P lyase activity and that the lyase may represent a novel immunosuppressant drug target.
淋巴细胞从胸腺和外周淋巴器官的输出依赖于1-磷酸鞘氨醇(S1P)受体-1,并且被认为是对循环中的S1P作出的反应。然而,淋巴器官与血液或淋巴之间的S1P梯度的存在尚未得到证实。为了进一步明确输出的必要条件,我们探讨了为何用食用色素2-乙酰基-4-四羟基丁基咪唑(THI)处理会导致淋巴细胞减少。我们发现,小鼠淋巴组织中的S1P丰度通常较低,但在THI处理后增加了100多倍,并且这种处理会抑制S1P降解酶S1P裂解酶。我们得出结论,淋巴细胞的输出是由S1P裂解酶活性建立的S1P梯度介导的,并且该裂解酶可能代表一种新型免疫抑制药物靶点。